Nocapyrones A−D, γ-Pyrones from aNocardiopsisStrain Isolated from the Marine SpongeHalichondria panicea by Schneemann, Imke et al.
Nocapyrones A-D, γ-Pyrones from a Nocardiopsis Strain Isolated from the Marine Sponge
Halichondria panicea
Imke Schneemann, Birgit Ohlendorf, Heidi Zinecker, Kerstin Nagel, Jutta Wiese, and Johannes F. Imhoff*
Kieler Wirkstoff-Zentrum (KiWiZ) at the Leibniz-Institute of Marine Sciences (IFM-GEOMAR), Am Kiel-Kanal 44, 24106 Kiel, Germany
ReceiVed May 11, 2010
Four new γ-pyrones, nocapyrones A-D (1-4), were isolated from an organic extract of the Nocardiopsis strain HB383,
which was isolated from the marine sponge Halichondria panicea. These are the first γ-pyrones reported from a
Nocardiopsis strain. The structures were elucidated on the basis of one- and two-dimensional NMR experiments and
supported by HPLC-UV/MS and HRESIMS analyses. The biosynthesis of nocapyrone A was investigated by feeding
experiments with 13C-labeled compounds. In addition, one diketopiperazine, which was only known as a synthetic
compound before, was isolated. The bioactivies of 1, 2, and the diketopiperazine were evaluated in a panel of assays.
Nocardiopsis belongs to the Actinobacteria and was designated
as a distinct genus in 1976.1 It is set apart from similar genera
such as Actinomadura, Nocardia, and Streptomyces by character-
istics such as type of sporulation, morphology of aerial and substrate
mycelium, cell wall lipid composition, and susceptibility to
lysozyme.1 Due to the wide distribution of members of the genus,
it is not surprising that it has already been isolated from marine
sponges as well. Considering the facts that Actinobacteria are
exceptionally potent producers of secondary metabolites and that
the rediscovery rates of known compounds are high in intensively
studied genera such as Streptomyces species, strategies such as
focusing on less common taxa, e.g., Nocardiopsis species, and
isolating bacteria from extraordinary and promising habitats such
as sponges have become more and more popular.2,3 Halichondria
panicea is a sponge species suitable for such an approach, because
it has been reported to harbor a vast number of different
microorganisms, among them also several Actinobacteria.4 The
majority of Actinobacteria isolated from H. panicea belong to the
well-studied genus Streptomyces. Among 46 actinobacterial isolates
from H. panicea only one was classified as belonging to the genus
Nocardiopsis.5
Nocardiopsis strain HB383 was chosen for further investigations
due to unidentified peaks in the LC-UV/MS chromatogram and
antibacterial activity of the organic extract. This strain was selected
in a study focusing on the discovery of new secondary metabolites
from marine Actinobacteria associated with the sponge H. panicea.5
By 16S rRNA gene sequence analysis this strain was identified as
a member of the genus Nocardiopsis with 99.8% similarity to
Nocardiopsis alba DSM 43377T. The HPLC-MS analysis of the
EtOAc extract displayed four main peaks in the UV chromatogram,
which could be assigned to the masses 334, 320, 286, and 268. On
the basis of UV, mass, and NMR data the first three peaks
presumably belonged to a number of diketopiperazines that have
not yet been described for Nocardiopsis species. The fourth peak
belonged to a new γ-pyrone, which, together with three derivatives,
will be introduced in this paper.
With the aim of obtaining the new metabolites, the extract was
separated using preparative reversed-phase (C18) HPLC, which
yielded nocapyrones A (1) and B (2). Another HPLC fraction
yielded the derivatives nocapyrones C (3) and D (4) after further
purification.
Nocapyrones A (1) and B (2) were amorphous, colorless solids
with molecular weights of m/z 269.1847 [M + H]+ and 253.1805
[M + H]+, respectively. These results of the high-resolution mass
measurements yielded the molecular formulas of C15H24O4 for 1
and C15H24O3 for 2, which were entirely consistent with the
spectroscopic data. The structure elucidation of the two compounds
was mainly based on the NMR spectra of 1. The respective 13C
NMR spectrum displayed 14 distinct signals. Not only was the
signal of C-11/12 (δC 29.4) much more intense than the other carbon
signals, but the corresponding 1H signal additionally integrated to
six protons, which evidenced the presence of two magnetically
equivalent methyl groups. Three additional methyl groups, C-13
(δC 10.3), C-14 (δC 7.2), and C-15 (δC 56.5), were present, with
the shift of C-15 proving it to be a methoxy group. Furthermore,
the molecule comprised a chain of four methylene groups, CH2-6
to CH2-9 (δC 31.7, δH 2.72; δC 28.8, δH 1.71; δC 25.0, δH 1.46;
and δC 44.5, δH 1.50), and four olefinic quaternary carbons, C-1
(δC 164.8), C-2 (δC 100.2), C-4 (δC 119.3), and C-5 (δC 161.4).
Two of these quaternary carbons, C-1 and C-5, were located
adjacent to oxygen atoms as proven by their 13C resonances of 164.8
and 161.4 ppm. Finally, the signal with a chemical shift of 183.4
ppm gave evidence of a carbonyl function being present. A 1H-13C
HSQC spectrum correlated all proton resonances to the correspond-
ing 13C NMR resonances of directly bonded carbon atoms. A 1H-1H
COSY spectrum revealed that the methylene groups constitute the
only coherent spin system, which later was identified as belonging
to the side chain of a γ-pyrone core structure. The final structure
of the molecule was elucidated with the help of a 1H-13C HMBC
spectrum (Figure 1).
The molecular formula C15H24O4 implied four degrees of
unsaturation, meaning that apart from the carbonyl group and two
double bonds, one ring had to be part of the structure. This was in
good agreement with a γ-pyrone moiety being the core structure
of the molecule. This deduction was additionally supported by the
UV maxima (253 and 215 nm), which fit nicely with literature data
of γ-pyrones.6 Consequently, the γ-pyrone skeleton consisted of
the olefinic carbons and the carbonyl group, C-1 to C-5, with C-1
and C-5 being connected via an oxygen atom. The 1H chemical
shifts of CH3-13 and CH3-14 as well as their 1H-13C HMBC
correlations to the quaternary carbon atoms clearly showed that
they were located at positions 2 and 4 of the γ-pyrone ring (HMBC
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correlations from H3-13 (δH 1.94) to C-3, C-4, and C-5 and from
H3-14 (δH 1.81) to C-1, C-2, and C-3). The methoxy group OCH3-
15 was also directly attached to the pyrone ring, as shown by the
correlation of the resonance of H3-15 (δH 4.03) to the resonance of
C-1. Therefore, the methoxy group had to be attached to C-1. The
H-6 signal correlated to the signals of C-7 and C-8, as well as to
those of C-4 and C-5. As mentioned above, the CH2 groups CH2-6
to CH2-9 formed a spin system, as shown by strong COSY
correlations and the resulting multiplicities of the signals. The
methylene chain terminates with the quaternary carbon C-10 (δC
71.4), which is substituted with the equivalent methyl groups CH3-
11 and CH3-12 (δC 29.4, δH 1.17) as well as a hydroxy group. All
spectroscopic data are in good accordance with the determined
structure.
Overall, the 1H NMR chemical shifts of nocapyrone B (2) were
close to being identical to those of nocapyrone A (1). The only
differences were the appearance of an additional signal for H-10
(δH 1.60) and the upfield shift of the signal of the methyl protons
H3-11 and H3-12 (δH 0.93). The upfield shift already indicated the
loss of the hydroxy group. This assumption was further supported
by the mass difference of 16 and the fact that the signal of the
methyl groups in question now appeared as a doublet due to
coupling with H-10. Thus, the structure of nocapyrone B (2) was
established.
The UV spectra of nocapyrones C (3) and D (4) were almost
identical to those of the other two derivatives. Consequently, the
chromophore of the structures was very likely to be the same. This
was proven by analyses of one- and two-dimensional NMR spectra
(Table 2 and SI). The 1H NMR and 13C NMR shifts of the methyl
groups CH3-13, CH3-14, and CH3-15 as well as their 1H-13C
HMBC correlations fit perfectly with the assigned γ-pyrone
substructure. Thus, similar to 1 and 2, the structures of 3 and 4
differed only in the side chain of the molecule. The molecular
formulas C16H26O4 for 3 and C16H24O4 for 4 proved the chain to
be longer than those of the nocapyrones A (1) and B (2). Due to
uniformity in the UV and MS data of compound 3, but doubled
signals in NMR measurements, we presume the presence of two
isomers of compound 3. Like 1, nocapyrone C had two methyl
groups, CH3-12 (δC 20.0, δH 1.11) and CH3-16 (δC 14.9, δH 0.88),
included in the aliphatic side chain, each of them forming a doublet
in the 1H NMR spectrum. The terminal methyl group CH3-12
showed a 1H-1H COSY correlation to H-11 (δH 3.62) and
additionally a 1H-13C HMBC correlation to C-10 (δC 40.8), which
established the sequence from C-12 to C-10. The shift of CH-11
(δH 3.62, δC 71.8) proved it to be an oxygen-bearing methine,
whereas CH-10 (δH 1.45) was the methine group located adjacent
to CH3-16. The side chain was completed by the methyl groups
CH2-6 (δH 2.72, δC 31.5) to CH2-9 (δH 1.3-1.5, δC 33.3). Compared
to 3, in the 1H NMR spectrum of nocapyrone D (4) only one of
the side chain methyl groups, CH3-16 (δH 1.08, δC 16.5), appeared
as a doublet. The other one appeared as a singlet at δH 2.14 and δC
28.3 ppm. These data suggested the terminal methyl group to be
connected to a carbonyl carbon. Compared to nocapyrone C, there
is no oxygen-bearing methine group in 4. Instead C-10 is a
quaternary carbon with a shift of 215.3 ppm, which showed it to
be a keto group. Thus, the only difference between the nocapyrones
C and D is the hydroxy group in the former that is replaced by a
keto group in the latter.
Although these are the first γ-pyrones described from a Nocar-
diopsis strain, natural products based on such a substructure are
widespread and constitute a large class of biologically active
compounds.7,8 Compounds containing the same dimethylated and
methoxylated pyrone substructure as the nocapyrones are relatively
common, with examples being aureothin9 and actinopyrone,6 which
was first reported to have vasodilating and antibacterial activities.
Further studies complemented this activity spectrum with promising
activities against Helicobacter pylori.10
According to the widespread nature of γ-pyrone, the biosynthesis
of structures related to the nocapyrones has been studied before.
Molecules belonging to this compound class have been reported
to be synthesized via different pathways including type I, type II,
and type III PKSs.11 A bacterial γ-pyrone with a well-explored
biosynthesis is the Streptomyces metabolite aureothin.9 Aureothin
is a type I PKS product generated by the assembly of a p-
nitrobenzoate starter unit, one acetate, and four propionate building
blocks.
By analogy, we suggest nocapyrone A to be a polyketide
composed of an isobutyrate starter unit, two acetates, and two
propionate building blocks. Results of feeding experiments with
13C-labeled acetate, propionate, and methionine (see Figure 2 and
SI) support this assumption; that is, feeding of 1-13C-propionate
led to an enhancement of the 13C NMR signals of C-1 and C-3.
The analogous experiment with 1-13C-acetate resulted in an
intensification of the carbon resonances of C-5 and C-7. Finally,
the signal of C-15 became enhanced after feeding with [Me-13C]
methionine, which demonstrated the methyl group to be S-
adenosylmethionine (SAM)-derived. Therefore, in a similar fashion
to that described for aureothin we propose the formation of an
R-pyrone that is transformed to the γ-pyrone in the course of the
methylation by an O-methyltransferase.
Despite the inhibition of the Gram-positive bacteria Staphylo-
coccus lentus and Bacillus subtilis by the extract, the isolated
nocapyrones A (1) and B (2) showed no bioactivities against a range
of Gram-positive and Gram-negative bacteria and the yeast Candida
glabrata. Furthermore, in Vitro cytotoxicity analyses revealed no
activity against the mouse fibroblast cell line NIH-3T3 as well as
the human hepatocellular carcinoma cell line HepG2 and the human
colon adenocarcinom cell line HT-29. Additionally, 1 and 2 did
not inhibit phosphodiesterase 4, protein tyrosine phosphatase 1B,
acetylcholinesterase, reverse transcriptase, or glycogen synthase
kinase 3.
As already mentioned above, strain HB383 produces not only
the nocapyrones but also three molecules belonging to the dike-
topiperazine compound class. As far as these compounds are
concerned, only ones(2E/5Z)-2-[(4-methoxyphenyl)methylene]-5-
(2-methylpropylidene)-3,6-piperazinedione (5) (Figure 3)scould be
sufficiently purified for structure elucidation. The molecular formula
C16H18N2O3 of 5 was established by HRESIMS (m/z 309.1219 [M
+ Na]+, calcd 309.1210), and the structure was elucidated based
Figure 1. Selected COSY (bold lines) and HMBC correlations
(arrows) of nocapyrone A.
Table 1. NMR Spectroscopic Data (500 MHz, Methanol-d4) for
Nocapyrone A (1)






6 31.7, CH2 2.72, t (7.5) 4, 5, 7, 8
7 28.8, CH2 1.71, tt (7.5, 7.5) 5, 6, 8, 9
8 25.0, CH2 1.46, m 6, 7, 9
9 44.5, CH2 1.50, m 8, 10, 11/12
10 71.4, C
11/12 29.4, CH3 1.17, s 9, 10, 11/12
13 10.3, CH3 1.94, s 3, 4, 5
14 7.2, CH3 1.81, s 1, 2, 3
15 56.5, CH3 4.03, s 1
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on 1D and 2D NMR experiments (1H, 13C, 1H-1H-COSY, 1H-13C-
HSQC, and 1H-13C-HMBC). The data matched those of a synthetic
compound perfectly,12 but it was isolated from a natural source
for the first time.
Compound 5 was isolated as a mixture of two isomers. Even
though they seemed to be separable by HPLC, the single compounds
rapidly reverted to a mixture again, which led to doubled sets of
signals in the NMR spectra. With two double bonds in the molecule,
the formation of four different isomers is possible, yet only two
were observed. As the two double bonds ∆5,7 and ∆2,11 are
trisubstituted, the configuration could not be deduced from the
coupling constants of connected protons. Therefore, a NOESY
spectrum was measured in order to clarify the configurations of
the double bonds. H-4 exhibited NOESY correlations to H-8, but
not to H-7 in both isomers. Thus, ∆5,7 must be Z-configured in
both derivatives. Contrary to that, a NOESY correlation from H-1
to H-11 was observed in one of the isomers, but not in the other.
Therefore, isomerization of the ∆2,11 double bond readily occurs
under the applied conditions.
Compound 5 exhibited weak cytotoxic activity. The treatment
of NIH-3T3 and HepG2 cells with 50 µM 5 resulted in a reduction
of the metabolic activities by 64% and 44%, respectively.
Although 5 is described for the first time as a natural product,
and Nocardiopsis strains have not been reported to produce
diketopiperazines so far, this compound class is ubiquitous, and
very similar structures with dehydro amino acids, such as al-
bonoursin,13 have already been described from Streptomyces
strains.13,14 Two of them are XR334 and XR330, which are
diketopiperazines consisting of dehydromethyltyrosine and dehy-
drophenylalanine and its N-methylated derivative. For these two
compounds molecular weights of 320.34 and 334.37, respectively,
have been reported, which fit in well with the peaks detected in
the extract of strain HB383.
Experimental Section
General Experimental Procedures. The optical rotation was
measured on a Perkin-Elmer model 241 polarimeter. UV spectra were
obtained on a NanoVue (GE Healthcare). NMR spectra were recorded
on a Bruker DRX500 spectrometer (500 and 125 MHz for 1H and 13C
NMR, respectively), using the signals of the residual solvent protons
and the solvent carbons as internal references (δH 3.31 and δC 49.0
ppm for methanol-d4; δH 2.50 and δC 39.51 ppm for DMSO-d6). High-
resolution mass spectra were acquired on a benchtop time-of-flight
spectrometer (MicrOTOF, Bruker Daltonics) with positive electrospray
ionization. Analytical reversed-phase HPLC-UV/MS experiments were
performed using a C18 column (Phenomenex Onyx Monolithic C18,
100 × 3.00 mm) applying an H2O (A)/MeCN (B) gradient with 0.1%
HCOOH added to both solvents (gradient: 0 min 5% B, 4 min 60% B,
6 min 100% B; flow 2 mL/min) on a VWR Hitachi Elite LaChrom
system coupled to an ESI-ion trap detector (Esquire 4000, Bruker
Daltonics). Preparative HPLC was carried out using a Merck Hitachi
system consisting of an L-7150 pump, an L-2200 autosampler, and an
L-2450 diode array detector and a Phenomenex Gemini C18 110A
AXIA, 100 × 21.20 mm, or a Phenomenex Luna silica 5 µm, 250 ×
10.00 mm column.
Isolation and Identification of Nocardiopsis sp. HB383. Strain
HB383 was obtained from the marine sponge Halichondria panicea
collected from the Baltic Sea (Germany). DNA extraction, 16S rRNA
amplification, and 16S rRNA gene sequencing as well as the comparison
of this sequence (1395 nucleotides; GenBank/EMBL/DDBJ acc. no
GQ863933) with sequences in the EMBL nucleotide database available
online at the European Bioinformatics Institute homepage using the
Basic Local Alignment Search Tool (nucleotide BLAST) and of RDP-
II Project homepage were done as described in Schneemann et al.5
The sequence analysis revealed that the strain was affiliated with the
genus Nocardiopsis. The most closely related type strain was Nocar-
diopsis alba DSM 43377T (GenBank/EMBL/DDBJ acc. no. X97883)
with a sequence identity of 99.8%.
Cultivation. For chemical analyses Nocardiopsis sp. HB383 was
grown in GYMCaCl2 medium (0.4 g glucose, 0.4 g yeast extract, 0.4 g
malt extract, 0.2 g CaCl2, 1 L H2O, pH 7.2) for 18 days at 28 °C and
120 rpm in 12 × 2000 mL Erlenmeyer flasks in the dark. Each flask
was inoculated with 10 mL of a 3-day-old GYM4 preculture (0.4 g
glucose, 0.4 g yeast extract, 0.4 g malt extract, 0.2 g CaCO3, 100 mL
H2O, pH 7.2; 120 rpm, 28 °C). These precultures were inoculated with
cryoconserved cultures of strain HB383.
Isolation of Nocapyrones A-D and 5. The culture broth (12 L)
was homogenized with an Ultra Turrax T25 basic (IKA-Werke GmbH
Table 2. 13C and 1H NMR (500 MHz, methanol-d4) Spectroscopic Data for Nocapyrones B-D (2-4)
nocapyrone B (2) nocapyrone C (3) nocapyrone D (4)
position δC δH δC δH δC δH
1 164.9 164.6 164.8
2 100.0 100.1 99.8
3 183.3 183.2 182.7
4 119.2 119.2 119.0
5 161.8 161.3 161.0
6 31.5 2.70, t (7.5) 31.5 2.72, t (7.5) 31.4 2.70, t (7.5)
7 27.9 1.69, quintet (7.5) 27.7 1.71, m (7.5) 27.7 1.71, quintet (7.5)
8 30.2 1.42, m 33.5 1.3-1.5, m 31.2 1.28-1.45, m
9 39.7 1.31, m 33.3 1.3-1.5, m 33.4 1.28-1.45, m
10 29.2 1.55, septet (6.8) 40.8 1.45, m 47.4 2.59, sextet (6.8)
11 22.9 0.90, d (6.8) 71.8 3.62, dq (6.2, 4.6) 215.3
12 22.9 0.90, d (6.8) 20.0 1.11, d (6.2) 28.3 2.14, s
13 10.2 1.93, s 10.1 1.93, s 10.1 1.93, s
14 7.0 1.81, s 7.0 1.81, s 7.0 1.81, s
15 56.3 4.03, s 56.4 4.03, s 56.3 4.03, s
16 14.9 0.88, d (6.9) 16.5 1.08, d (7.0)
Figure 2. Biosynthetic origin of nocapyrone A as determined by
13C-labeling.
Figure 3. Selected 1H-13C HMBC (f) and NOESY correlations
(T) of (2E/5Z)-2-[(4-methoxyphenyl)methylene]-5-(2-methylpro-
pylidene)-3,6-piperazinedione (5).
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and Co., Staufen, Germany) at 16 000 rpm for 30 s and extracted with
6 L of EtOAc. The solution was dried to yield 804 mg of an organic
extract. An aliquot was analyzed with HPLC-UV/MS. Nocapyrones A
(1) and B (2) were detected at 3.2 and 4.5 min, respectively.
Subsequently, the extract was subjected to preparative HPLC
(eluents: H2O (A), MeCN (B); gradient 0 min 5% B, 16 min 70% B,
16.5 min 100% B; flow 18 mL/min). Nocapyrones A (3.7 mg) and B
(0.3 mg) eluted at 6.5 and 9.1 min, respectively.
Nocapyrones C (3) and D (4) were isolated out of combined extracts
that were fractionated on a Sephadex LH 20 column with MeOH as
eluent. One fraction (approximately 20 mg) yielded 4.8 mg of crude 3
and 2.6 mg of crude 4 by HPLC separation (45% ACN to 55% ACN
in 13 min). Compounds 3 and 4 eluted at 4.8 and 5.5 min, respectively.
The compounds were purified further on a semipreparative normal-
phase column. Applying a gradient from 2-propanol/hexane (25:75) to
2-propanol/hexane (20:80) in 16 min and a flow of 5 mL/min, the
derivatives eluted at 7.2 min (3) (0.9 mg of a mixture of two isomers)
and 9.1 min (4) (0.2 mg), respectively.
Compound 5 precipitated in the MeOH extracts as a colorless solid.
Part of the precipitate was washed with H2O several times. Subsequently
MeOH (4 × 1 mL) was added. The supernatant was subjected to
preparative HPLC, and separation was carried out by a H2O/ACN
gradient of 45% ACN to 90% ACN in 13 min. Compound 5 eluted at
5.0 min (0.6 mg of a mixture of two isomers).
Biosynthetic Studies. For the labeling experiments 1-13C-sodium
acetate, 1-13C-sodium propionate, and methyl-13C-methionine with 99%
13C were used (Cambridge Isotope Laboratories, Isotec, and Aldrich).
The strain HB383 was cultivated in the same liquid medium as
described above (GYMCaCl2). In each feeding experiment, the pre-
culture was grown for three days in 100 mL of medium. A 1 mL amount
of the preculture was added to each of 15 Erlenmeyer flasks with 100
mL of medium for the main culture. Together with the inoculum the
labeled compounds (500 mg 1-13C-sodium acetate, 500 mg 1-13C-
sodium propionate, and 17 mg methyl-13C-methionine) were added in
the form of sterile filtered solutions (dissolved in H2O). The isolation
of nocapyrone A was carried out according to the isolation procedure
described above. The yields of labeled nocapyrone A were ap-
proximately 1 mg in each batch.
Nocapyrone A (1): colorless, amorphous solid; UV (MeOH) λmax
(log ε) 253 (4.06), 204 (4.00) nm; for 1D and 2D NMR data see Table
1 and SI; HRESIMS m/z 269.1847 [M + H]+ (calcd for C15H25O4,
269.1847).
Nocapyrone B (2): colorless, amorphous solid; UV (MeOH) λmax
(log ε) 253 (4.02), 209 (4.07) nm; for 1D and 2D NMR data see Table
2 and SI; HRESIMS m/z 253.1805 [M + H]+ (calcd for C15H25O3,
253.1798).
Nocapyrone C (3): colorless, amorphous solid; [R]20D +11 (c 0.07,
MeOH); UV (MeOH) λmax (log ε) 253 (4.06), 204 (4.00) nm; for 1D
and 2D NMR data see Table 2 and SI; HRESIMS m/z 283.1903 [M +
H]+ (calcd for C16H26O4, 283.1903).
Nocapyrone D (4): colorless, amorphous solid; [R]20D +120 (c
0.005, MeOH); UV (MeOH) λmax (log ε) 253 (4.06), 205 (4.10) nm;
for 1D and 2D NMR data, see Table 2 and SI; HRESIMS m/z 281.1749
[M + H]+ (calcd for C16H24O4, 281.1747).
Antibacterial Activities. Antimicrobial assays of compounds 1, 2,
and 5 were performed using Bacillus subtilis (DSM 347), Erwinia
amyloVora (DSM 50901), Escherichia coli K12 (DSM 498), Pseudomo-
nas fluorescence (NCIMB 10586), Propionibacterium acnes (DSM
1897), Pseudomonas aeruginosa (DSM 50071), Pseudomonas syringae
pv aptata (DSM 50252), Ralstonia solanacearum (DSM 9544),
Staphylococcus epidermidis (DSM 20044), Staphylococcus lentus (DSM
6672), Xanthomonas campestris (DSM 2405), and the yeast Candida
glabrata (DSM 6425). The assays were performed according to
Schneemann et al.15
Cytotoxicity Assays. The sensitivity of the cell lines NIH-3T3,
HepG2, and HT29 to the isolated compounds (1, 2, and 5) was evaluated
by monitoring the metabolic activity according to Schneemann et al.15
Enzyme Inhibitory Activity. See the Supporting Information.
Acknowledgment. The authors gratefully thank Dr. I. Kajahn for
fruitful discussions, K. Schumann for cultivation experiments, A. Erhard
for bioactivity assays, and G. Kohlmeyer-Yilmaz, M. Ho¨ftmann, and
Prof. Dr. F. So¨nnichsen (University of Kiel, Germany) for running and
processing NMR experiments. This study is from the Kieler Wirkstoff-
Zentrum KiWiZ at the Leibniz Institute of Marine Sciences IFM-
GEOMAR and was supported by the Ministry of Science, Economic
Affaires and Transport of the State of Schleswig-Holstein (Germany)
in the frame of the “Future Program for Economy”, which is co-financed
by the European Union (EFRE).
Supporting Information Available: Additional information such
as 1H NMR spectra of 1-5, 13C NMR spectra of 1, NMR spectra of
labeling experiments and spectroscopic data of 2-5, as well as the
description of enzyme inhibitory activity are available free of charge
via the Internet at http://pubs.acs.org.
References and Notes
(1) Meyer, J. Int. J. Syst. Bacteriol. 1976, 26, 487–493.
(2) Herna´ndez, L. M. C.; De la Fuente Blanco, J. A.; Baz, J. P.; Puentes,
J. L. F.; Milla´n, F. R.; Va´zquez, F. E.; Ferna´ndez-Chimeno, R. I.;
Gravalos, D. G. J. Antibiot. 2000, 53, 895–902.
(3) Chelossi, E.; Pantile, R.; Pronzato, R.; Milanese, M.; Hentschel, U.
Aquat. Microb. Ecol. 2007, 49, 157–163.
(4) Imhoff, J. F.; Sto¨hr, R. In Molecular Marine Biology of Sponges;
Mu¨ller, W. E. G., Ed.; Springer-Verlag: Berlin, 2003; Vol. 1, pp 35-
57.
(5) Schneemann, I.; Nagel, K.; Kajahn, I.; Labes, A.; Wiese, J.; Imhoff,
J. F. Appl. EnViron. Microbiol. 2010, 76, 3702–3714.
(6) Yano, K.; Yokoi, K.; Sato, J.; Oono, J.; Kouda, T.; Ogawa, Y.;
Nakashima, T. J. Antibiot. 1986, 39, 38–43.
(7) Yoshida, M.; Hara, M.; Saitoh, Y.; Sano, H. J. Antibiot. 1990, 43,
1519–1523.
(8) Wilk, W.; Waldmann, H.; Kaiser, M. Bioorg. Med. Chem. 2009, 17,
2304–2309.
(9) He, J.; Hertweck, C. Chem. Biol. 2003, 10, 1225–1232.
(10) Taniguchi, M.; Watanabe, M.; Nagai, K.; Suzumura, K.-I.; Suzuki,
K.-I.; Tanaka, A. J. Antibiot. 2000, 53, 844–847.
(11) Busch, B.; Hertweck, C. Phytochemistry 2009, 70, 1833–1840.
(12) Wang, L. X.; Shi, Y. Z.; Xu, M. H.; Hu, H. W. Org. Prep. Proc. Int.
1996, 28, 226–230.
(13) Kanzaki, H.; Yanagisawa, S.; Nitoda, T. J. Antibiot. 2000, 53, 1257–
1264.
(14) Bryans, J.; Charlton, P.; Chicarelli-Robinson, I.; Collins, M.; Faint,
R.; Latham, C.; Shaw, I.; Trew, S. J. Antibiot. 1996, 49, 1014–1021.
(15) Schneemann, I.; Kajahn, I.; Ohlendorf, B.; Zinecker, H.; Erhard, A.;
Nagel, K.; Wiese, J.; Imhoff, J. F. J. Nat. Prod. 2010, 73, 1309–1312.
NP100312F
Notes Journal of Natural Products, 2010, Vol. 73, No. 8 1447
